This transcript has been edited for clarity.
Ileana L. Piña, MD, MPH: Hello. I'm Ileana Piña from Thomas Jefferson University, and this is my blog. I'm thrilled that we're together in person at the American College of Cardiology in Washington, DC. It's been a good 3 years since many of us have seen each other in person. It's been really wonderful to see my colleagues and friends, and I have one of them here with me today.
Dr Justin Ezekowitz and I have worked together on many projects, including the VICTORIA trial, and we suffered through the GUIDE-IT trial. He is a professor of medicine at the University of Alberta in Alberta, Canada. I want to welcome you.
You and I have had so many discussions about the right drugs, but you're presenting the SODIUM-HF trial.
Justin A. Ezekowitz, MBBCh, MSc: That's right. This was a long trial.
Finger-Wagging Patients to Restrict Sodium
Piña:One of my pet peeves about diet is that we're telling these patients, "You have to take all these drugs and now there's four pillars of care, but you also have to cut down your sodium and you have to read the food labels." Then you ask, "Where are the data?"
Cardiologists, Patients Can Talk Drug Costs
Early or Delayed AF Ablation After Heart Failure Hospitalization?
Skill Checkup: A 69-Year-Old Woman With Worsening Heart Failure and Iron Deficiency
COMMENTARY
SODIUM-HF Simplifies Message to Patients on Diet
Interviewer: Ileana L. Piña, MD, MPH; Interviewee: Justin A. Ezekowitz, MBBCh, MSc
DisclosuresApril 08, 2022
This transcript has been edited for clarity.
Ileana L. Piña, MD, MPH: Hello. I'm Ileana Piña from Thomas Jefferson University, and this is my blog. I'm thrilled that we're together in person at the American College of Cardiology in Washington, DC. It's been a good 3 years since many of us have seen each other in person. It's been really wonderful to see my colleagues and friends, and I have one of them here with me today.
Dr Justin Ezekowitz and I have worked together on many projects, including the VICTORIA trial, and we suffered through the GUIDE-IT trial. He is a professor of medicine at the University of Alberta in Alberta, Canada. I want to welcome you.
You and I have had so many discussions about the right drugs, but you're presenting the SODIUM-HF trial.
Justin A. Ezekowitz, MBBCh, MSc: That's right. This was a long trial.
Finger-Wagging Patients to Restrict Sodium
Piña:One of my pet peeves about diet is that we're telling these patients, "You have to take all these drugs and now there's four pillars of care, but you also have to cut down your sodium and you have to read the food labels." Then you ask, "Where are the data?"
© 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: SODIUM-HF Simplifies Message to Patients on Diet - Medscape - Apr 08, 2022.
Tables
Authors and Disclosures
Authors and Disclosures
Interviewer
Ileana L. Piña, MD, MPH
Professor of Medicine/Cardiology/Heart Failure/Transplant; Quality Officer, Cardiovascular Line, Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania; Clinical Professor of Medicine, Central Michigan University College of Medicine, Mount Pleasant, Michigan; Adjunct Professor of Epidemiology and Biostatistics, Population & Quantitative Health Sciences, Case Western University, Cleveland, Ohio
Disclosure: Ileana L. Piña, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, office, partner, employee, advisor, consultant, or trustee for: US Food and Drug Administration; Center for Devices and Radiological Health
Interviewee
Justin A. Ezekowitz, MBBCh, MSc
Professor of Medicine, Division of Cardiology, University of Alberta; Cardiologist, Mazankowski Alberta Heart Institute; Co-director, Canadian VIGOUR Centre; Director, Cardiovascular Research, University of Alberta, Edmonton, Alberta, Canada
Disclosure: Justin A. Ezekowitz, MBBCh, MSc, has disclosed the following relevant financial relationships:
Served as a consultant: AstraZeneca; Bristol-Myers Squibb;
Novartis; Novo Nordisk Inc.; Otsuka Pharmaceutical Co.; Pfizer; servier
Performed research or received research grants: American Regent; Amgen; Bayer Healthcare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc; Cytokinetics; Merck & Co., Inc.